SCHEMBL5137219

SCHEMBL5137219

O=C(c1cn(Cc2ccccn2)c2cc(Cl)ccc12)N1CC2(CCNCC2)c2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 6/20 0.39
ADRA1D P25100 1/20 0.37
SLC22A12 Q96S37 1/20 0.37
CYP2D6 P10635 1/20 0.37
ROCK2 O75116 1/20 0.36
ROCK1 Q13464 1/20 0.36
AKT1 P31749 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
TACR3 P29371 1/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
NOTUM Q6P988 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4822866 0.88 AVPR1A (0.40) AVPR1ACYP2D6ROCK2ROCK1AKT1
SCHEMBL5137426 0.86 CNR1 (0.42) AVPR1AADRA1DCYP2D6ROCK2ROCK1
SCHEMBL4359444 0.76 AVPR1A (0.59) AVPR1AADRA1DSLC22A12TACR3MEN1
SCHEMBL14268287 0.75 AVPR1A (0.46) AVPR1AADRA1DKDM4ETACR3
SCHEMBL5137944 0.75 SMN1; SMN2 (0.40) CYP2D6ROCK2ROCK1HDAC1HDAC6
SCHEMBL5138464 0.74 AVPR1A (0.54) AVPR1ACYP2D6ROCK2ROCK1NOTUM
SCHEMBL4359328 0.73 AVPR1A (0.70) AVPR1A
SCHEMBL4361148 0.73 AVPR1A (0.57) AVPR1ACYP2D6
SCHEMBL8251835 0.73 AVPR1A (0.48) AVPR1AADRA1DSLC22A12TACR3MEN1
SCHEMBL4759234 0.71 AVPR1A (0.41) AVPR1AMEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904477-A1 INDOL-3-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS F. Hoffmann-Roche AG (CH) 2008-04-02 EP disclosed
WO-2007006688-A1 INDOL-3-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-01-18 WO disclosed